Low Density Lipoprotein from Human Plasma

Low Density Lipoprotein from Human Plasma
Catalog number: B2010215
Lot number: Batch Dependent
Expiration Date: Batch dependent
Volume/Weight: 50 mg
pH: na
Supplied as: Ready-to-use
Appearance: Solution
Applications: human plasma derived Low-density lipoprotein (LDL), a lipoprotein that carries cholesterol.
Storage: -20C
Keywords: Low-density lipoprotein, LDL, beta-lipoprotein, cholesterol oxidized LDL, cholesterol low-density lipoprotein, cholesterin.
Grade: Biotechnology grade. All components are highly pure (minimum 99%). All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered on a 0.22 um.

References:
1: Hartley A, Haskard D, Khamis R. Oxidized LDL and anti-oxidized LDL antibodies
in atherosclerosis – Novel insights and future directions in diagnosis and
therapy. Trends Cardiovasc Med. 2019 Jan;29(1):22-26.

2: Motamed M, Nargesi AA, Heidari B, Mirmiranpour H, Esteghamati A, Nakhjavani
M. Oxidized Low-Density Lipoprotein (ox-LDL) to LDL Ratio (ox-LDL/LDL) and ox-
LDL to High-Density Lipoprotein Ratio (ox-LDL/HDL). Clin Lab. 2016 Sep
1;62(9):1609-1617.

3: Song Y, Hou M, Li Z, Luo C, Ou JS, Yu H, Yan J, Lu L. TLR4/NF-κB/Ceramide
signaling contributes to Ox-LDL-induced calcification of human vascular smooth
muscle cells. Eur J Pharmacol. 2017 Jan 5;794:45-51.

4: Wang M, Wu Y, Yu Y, Fu Y, Yan H, Wang X, Li T, Peng W, Luo D. Rutaecarpine
prevented ox-LDL-induced VSMCs dysfunction through inhibiting overexpression of
connexin 43. Eur J Pharmacol. 2019 Jun 15;853:84-92.

5: Fu C, Yin D, Nie H, Sun D. Notoginsenoside R1 Protects HUVEC Against Oxidized
Low Density Lipoprotein (Ox-LDL)-Induced Atherogenic Response via Down-
Regulating miR-132. Cell Physiol Biochem. 2018;51(4):1739-1750.

6: Yin R, Zhu X, Wang J, Yang S, Ma A, Xiao Q, Song J, Pan X. MicroRNA-155
promotes the ox-LDL-induced activation of NLRP3 inflammasomes via the ERK1/2
pathway in THP-1 macrophages and aggravates atherosclerosis in ApoE-/- mice. Ann
Palliat Med. 2019 Nov;8(5):676-689.

7: Chang W, Zhu F, Zheng H, Zhou Z, Miao P, Zhao L, Mao Z. Glucagon-like
peptide-1 receptor agonist dulaglutide prevents ox-LDL-induced adhesion of
monocytes to human endothelial cells: An implication in the treatment of
atherosclerosis. Mol Immunol. 2019 Dec;116:73-79.

8: Akhi R, Wang C, Kyrklund M, Kummu O, Turunen SP, Hyvärinen K, Kullaa A, Salo
T, Pussinen PJ, Hörkkö S. Cross-reactive saliva IgA antibodies to oxidized LDL
and periodontal pathogens in humans. J Clin Periodontol. 2017 Jul;44(7):682-691.

9: Yin J, Hou X, Yang S. microRNA-338-3p promotes ox-LDL-induced endothelial
cell injury through targeting BAMBI and activating TGF-β/Smad pathway. J Cell
Physiol. 2019 Jul;234(7):11577-11586.

Products Related to Low Density Lipoprotein from Human Plasma: Serum and Plasma